Squitieri & Fearon, LLP Announces Securities Fraud Suit Against Pozen Inc.


NEW YORK, June 9, 2004 (PRIMEZONE) -- The following statement was issued today by Squitieri & Fearon, LLP.

A class action has been filed in the United States District Court for the Middle District of North Carolina on behalf of persons who purchased or otherwise acquired securities of Pozen Inc. ("Pozen" or the "Company") (Nasdaq:POZN) during the period from July 31, 2003 through May 28, 2004.

If you wish to discuss your rights, please contact Stephen J. Fearon, Jr. of Squitieri & Fearon, LLP at (212) 421-6492 or by e-mail at Stephen@sfclasslaw.com.

The lawsuit charges that defendants violated the federal securities laws by issuing a series of materially false and misleading statements to the market about the Company's drugs called MT-100 and MT-300 which artificially inflated the price of the Company's securities.

If you purchased Pozen securities during the period from July 31, 2003 through May 28, 2004, you have until August 3, 2004 to ask the court to appoint you as a lead plaintiff.

If you wish to discuss this action or have any questions concerning this notice or your rights or interests, please contact Squitieri & Fearon, LLP.



            

Contact Data